Eisai is a global leading research-based pharmaceutical company working in the neurology and oncology therapeutic areas. Its UK facility, known as the
EMEA Knowledge Centre (EKC), is located 22 miles (35km) north of London.
Located within the “Golden Triangle” life sciences cluster of Oxford, Cambridge, London and England’s greater south-east, the EKC accommodates research, manufacturing and headquarter office facilities for the EMEA region on site.
We posed a number of questions to Andy Takle, VP and Head of Hatfield Research Laboratories, and Ajay Angris, Senior Director, UK Research Operations to better understand how the EKC has evolved, what advantages it
delivers and any future challenges. Both share their thoughts below, alongside information and contributions from Karen Foley, VP, Integrity and Site Management, Central Services and UK Site Operations, Paul Dale, EMEA Director of Estates, and Alex Felthouse, Managing Director of Eisai Manufacturing.
Left: Andy Takle, VP and Head of Hatfield Research Laboratories / Right: Ajay Angris, Senior Director, UK Research Operations
I understand that Eisai EMEA has been operational at the EMEA Knowledge Centre since 2009. Has the space always been used to accommodate R&D, production and HQ facilities?
Read the full story
Sign up
now to read the full story and get access to all posts for
paying subscribers only.
